FDA issued a Warning Letter to Megafine Pharma (P) Limited on 2/24/2017 for a previous inspection.
483 Megafine Pharma (P) Jun 2018

483 Megafine Pharma (P) Jun 2018

Marcellinus Dordunoo FDA$119.00 - Available Now

FDA investigators audited the Megafine Pharma (P) - Vapi, India facility and issued inspectional observations (via FDA 483) on 15 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Jun 2018
  • Location: Vapi, India
  • FEI: 3006688078
Add To Cart